论文部分内容阅读
自从国外于一九六一年首次报道P204对实验性矽肺有显著治疗效果以来,各国对该药的研究都很重视。在毛主席革命医疗卫生路线指引下,我国迅速合成该类药物克矽平,广泛进行了实验和临床研究,并肯定该药对矽肺有改善症状、阻止和延缓病变进展的效用①。与此同时,努力发掘祖国医药学宝库,实行中西医结合以防治矽肺的群众运动正朝气蓬勃地向前发展。我院从一九七一年三月以来曾分别应用单方草药石上柏或克矽平雾化吸入治疗矽肺,两组均取得一定疗效,现将资料完整的石上柏组121例,克矽平组90例,作比较分析如下:
Since the first overseas report of P204 on experimental silicosis in foreign countries in 1961, the study on this medicine has been taken seriously in many countries. Guided by Chairman Mao’s revolutionary medical and health pathways, our country rapidly synthesized such drugs as Kexiping and carried out extensive experimental and clinical studies. It also affirmed the utility of the drug in improving the symptoms of silicosis and preventing and retarding the progression of the disease. In the meantime, the mass movement that strives to discover the treasure trove of medicine in the motherland and integrates traditional Chinese and western medicine to prevent and cure silicosis is moving energetically forward. In our hospital from March 1971, they were treated with unilateral herb Shi Shang Bai or Ke Si Ping atomization inhalation for the treatment of silicosis, both groups have achieved a certain effect, the data are complete Shi Shang Bai group 121 cases, Ke Si Ping group 90 cases, for comparative analysis as follows: